" class="no-js "lang="en-US"> TB Alliance - Medtech Alert
Tuesday, August 12, 2025
TB Alliance | Pharmtech Focus

TB Alliance

About TB Alliance

TB Alliance

TB Alliance is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight TB. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. TB Alliance operates with support from Australia’s Department of Foreign Affairs and Trade; Bill & Melinda Gates Foundation; Foreign, Commonwealth and Development Office (United Kingdom); Cystic Fibrosis Foundation; Germany’s Federal Ministry of Education and Research through KfW; Global Disease Eradication Fund (Korea); Global Health Innovative Technology Fund; Indonesia Health Fund; Irish Aid; Korea International Cooperation Agency; Medical Research Council (United Kingdom); National Institute of Allergy and Infectious Diseases; Netherlands Ministry of Foreign Affairs; Republic of Korea’s Ministry of Foreign Affairs; and the United States Agency for International Development.

Related Story

PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials

August 18 2022

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of […]